These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28058825)

  • 21. The impact of vaccine procurement methods on public health in selected European countries.
    Wilsdon T; Lawlor R; Li L; Rafila A; García Rojas A
    Expert Rev Vaccines; 2020 Feb; 19(2):123-132. PubMed ID: 31990601
    [No Abstract]   [Full Text] [Related]  

  • 22. Progress introducing Haemophilus influenzae type b vaccine in low-income countries, 2004-2008.
    Wkly Epidemiol Rec; 2008 Feb; 83(7):61-7. PubMed ID: 18283719
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AAFP, AAP and ACIP release new childhood immunization schedule.
    Am Fam Physician; 1996 Jan; 53(1):395-6. PubMed ID: 8546057
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vaccination in children].
    Vandepitte J
    Rev Med Liege; 1997 Mar; 52(3):149-54. PubMed ID: 9213902
    [No Abstract]   [Full Text] [Related]  

  • 26. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process.
    Garpenholt O; Fredlund H; Timpka T
    Scand J Public Health; 2001 Dec; 29(4):271-8. PubMed ID: 11775783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommended childhood immunization schedule--United States, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Jan; 47(1):8-12. PubMed ID: 9450723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness.
    Chamberlain AT; Wells K; Seib K; Kudis A; Hannan C; Orenstein WA; Whitney EA; Hinman AR; Buehler JW; Omer SB; Berkelman RL
    J Public Health Manag Pract; 2012; 18(3):E9-E16. PubMed ID: 22473128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meeting of the immunization Strategic Advisory Group of Experts, November 2006--conclusions and recommendations.
    Wkly Epidemiol Rec; 2007 Jan; 82(1-2):1-16. PubMed ID: 17219693
    [No Abstract]   [Full Text] [Related]  

  • 32. New vaccine introductions in Africa before and during the decade of vaccines - Are we making progress?
    Sambala EZ; Wiyeh AB; Ngcobo N; Machingaidze S; Wiysonge CS
    Vaccine; 2019 May; 37(25):3290-3295. PubMed ID: 31076160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2015.
    Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Dietz V
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(39):1065-1071. PubMed ID: 27711036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in introduction of pneumococcal conjugate vaccine worldwide, 2000–2012.
    Wkly Epidemiol Rec; 2013 Apr; 88(17):173-80. PubMed ID: 23696979
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
    Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
    Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea.
    Choe YJ; Han OP; Cho H; Bae GR; Chun BC; Kim JH; Kim KH; Lee HJ; Choi EH
    Vaccine; 2014 Oct; 32(46):6049-53. PubMed ID: 25239482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine for India in the new millennium.
    Dutta AK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S1-5. PubMed ID: 11411379
    [No Abstract]   [Full Text] [Related]  

  • 38. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.
    Black S
    Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving child survival through immunisation.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Dec; 38(4):170-1. PubMed ID: 8143330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Review of the 2016 Swiss immunization schedule and technology update for improving vaccine management].
    Diana A
    Rev Med Suisse; 2016 May; 12(518):949-53. PubMed ID: 27352591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.